| 1 | [SID849990] | Active | Potency | 25.1189 | qHTS Assay for Activators of ClpP [AID651965, Type: confirmatory] | ClpP [Bacillus subtilis] [gi:2668494] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Activators of ClpP | | AID | 651965 | | BioAssay type | confirmatory | | Target | ClpP [Bacillus subtilis] [gi:2668494] | | PubMed | | | Data Table |  |
|
| 2 | [SID849990] | Active | Potency | 31.6228 | qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4 [AID893, Type: confirmatory] | Chain A, The Structure Of Wild-Type Human Hadh2 (17beta- Hydroxysteroid Dehydrogenase Type 10) Bound [gi:122921310] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4 | | AID | 893 | | BioAssay type | confirmatory | | Target | Chain A, The Structure Of Wild-Type Human Hadh2 (17beta- Hydroxysteroid Dehydrogenase Type 10) Bound [gi:122921310] | | PubMed | | | Data Table |  |
|
| 3 | [SID849990] | Active | | | Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis [AID588726, Type: screening] | Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis | | AID | 588726 | | BioAssay type | screening | | Target | Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504] | | PubMed | | | Data Table |  |
|
| 4 | [SID849990] | Active | | | Fluorescence-based biochemical high throughput confirmation assay for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis [AID651616, Type: screening] | Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical high throughput confirmation assay for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis | | AID | 651616 | | BioAssay type | screening | | Target | Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504] | | PubMed | | | Data Table |  |
|
| 5 | [SID849990] | Active | | | Non-Nucleoside Inhibitor of Measles Virus RNA-Dependent RNA Polymerase Complex Activity HTS Single Point (MLSMR Library) [AID841, Type: screening] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Active | | BioAssay | Non-Nucleoside Inhibitor of Measles Virus RNA-Dependent RNA Polymerase Complex Activity HTS Single Point (MLSMR Library) | | AID | 841 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID849990] | Active | | | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Fluroescence-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) assay to identify assay artifacts [AID652141, Type: screening] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Fluroescence-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) assay to identify assay artifacts | | AID | 652141 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID849990] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 8 | [SID849990] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 9 | [SID849990] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 10 | [SID849990] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 11 | [SID849990] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 12 | [SID849990] | Inactive | Potency | 35.4813 | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588456, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | Potency | 35.4813 [uM] | | BioAssay | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588456 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 13 | [SID849990] | Inactive | Potency | 35.4813 | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588456, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | Potency | 35.4813 [uM] | | BioAssay | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588456 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 14 | [SID849990] | Inactive | Potency | | qHTS Assay for Agonists of the Relaxin Receptor RXFP1 [AID2676, Type: confirmatory] | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Agonists of the Relaxin Receptor RXFP1 | | AID | 2676 | | BioAssay type | confirmatory | | Target | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] | | PubMed | | | Data Table |  |
|
| 15 | [SID849990] | Inactive | Potency | | qHTS Assay for Agonists of the Relaxin Receptor RXFP1 [AID2676, Type: confirmatory] | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Agonists of the Relaxin Receptor RXFP1 | | AID | 2676 | | BioAssay type | confirmatory | | Target | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] | | PubMed | | | Data Table |  |
|
| 16 | [SID849990] | Inactive | | | Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT) [AID488975, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | BioAssay | Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT) | | AID | 488975 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 17 | [SID849990] | Inactive | | | Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT) [AID488975, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | BioAssay | Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT) | | AID | 488975 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 18 | [SID849990] | Inactive | | | Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT) [AID488977, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | BioAssay | Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT) | | AID | 488977 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 19 | [SID849990] | Inactive | | | Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT) [AID488977, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | BioAssay | Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT) | | AID | 488977 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 20 | [SID849990] | Inactive | | | uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay [AID493012, Type: screening] | APOBEC3G gene product [Homo sapiens] [gi:13399304] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | BioAssay | uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay | | AID | 493012 | | BioAssay type | screening | | Target | APOBEC3G gene product [Homo sapiens] [gi:13399304] | | PubMed | | | Data Table |  |
|
| 21 | [SID849990] | Inactive | Potency | | qHTS for Inhibitors of Vif-A3G Interactions: qHTS [AID602310, Type: confirmatory] | APOBEC3G gene product [Homo sapiens] [gi:13399304] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Vif-A3G Interactions: qHTS | | AID | 602310 | | BioAssay type | confirmatory | | Target | APOBEC3G gene product [Homo sapiens] [gi:13399304] | | PubMed | | | Data Table |  |
|
| 22 | [SID849990] | Inactive | Potency | | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 23 | [SID849990] | Inactive | Potency | | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 24 | [SID849990] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate [AID2107, Type: confirmatory] | alpha-galactosidase [Homo sapiens] [gi:757912] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate | | AID | 2107 | | BioAssay type | confirmatory | | Target | alpha-galactosidase [Homo sapiens] [gi:757912] | | PubMed | | | Data Table |  |
|
| 25 | [SID849990] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate [AID2107, Type: confirmatory] | alpha-galactosidase [Homo sapiens] [gi:757912] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate | | AID | 2107 | | BioAssay type | confirmatory | | Target | alpha-galactosidase [Homo sapiens] [gi:757912] | | PubMed | | | Data Table |  |
|
| 26 | [SID849990] | Inactive | Potency | | qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5. [AID1467, Type: confirmatory] | alpha-galactosidase [Homo sapiens] [gi:757912] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5. | | AID | 1467 | | BioAssay type | confirmatory | | Target | alpha-galactosidase [Homo sapiens] [gi:757912] | | PubMed | | | Data Table |  |
|
| 27 | [SID849990] | Inactive | Potency | | qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5. [AID1467, Type: confirmatory] | alpha-galactosidase [Homo sapiens] [gi:757912] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5. | | AID | 1467 | | BioAssay type | confirmatory | | Target | alpha-galactosidase [Homo sapiens] [gi:757912] | | PubMed | | | Data Table |  |
|
| 28 | [SID849990] | Inactive | Potency | | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) [AID624417, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) | | AID | 624417 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 29 | [SID849990] | Inactive | Potency | | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) [AID624417, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) | | AID | 624417 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 30 | [SID849990] | Inactive | Potency | | qHTS of GLP-1 Receptor Agonists [AID624172, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Agonists | | AID | 624172 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 31 | [SID849990] | Inactive | Potency | | qHTS of GLP-1 Receptor Agonists [AID624172, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Agonists | | AID | 624172 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 32 | [SID849990] | Inactive | Potency | | qHTS for Inhibitors of Glutaminase (GLS) [AID624170, Type: confirmatory] | GLS protein [Homo sapiens] [gi:71051501] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Glutaminase (GLS) | | AID | 624170 | | BioAssay type | confirmatory | | Target | GLS protein [Homo sapiens] [gi:71051501] | | PubMed | | | Data Table |  |
|
| 33 | [SID849990] | Inactive | IC50 | | High Throughput Screening Assay for Hsp70 Inhibitors [AID583, Type: confirmatory] | heat shock 70kDa protein 1A [Homo sapiens] [gi:123271505] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | High Throughput Screening Assay for Hsp70 Inhibitors | | AID | 583 | | BioAssay type | confirmatory | | Target | heat shock 70kDa protein 1A [Homo sapiens] [gi:123271505] | | PubMed | | | Data Table |  |
|
| 34 | [SID849990] | Inactive | | | Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors: biochemical high-throughput screening assay to identify compounds that cause fluorescent intercalator displacement (FID) [AID1845, Type: screening] | NS3 [Hepatitis C virus] [gi:125541954] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | BioAssay | Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors: biochemical high-throughput screening assay to identify compounds that cause fluorescent intercalator displacement (FID) | | AID | 1845 | | BioAssay type | screening | | Target | NS3 [Hepatitis C virus] [gi:125541954] | | PubMed | | | Data Table |  |
|
| 35 | [SID849990] | Inactive | | | Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3) [AID1800, Type: screening] | NS3 [Hepatitis C virus] [gi:125541954] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3) | | AID | 1800 | | BioAssay type | screening | | Target | NS3 [Hepatitis C virus] [gi:125541954] | | PubMed | | | Data Table |  |
|
| 36 | [SID849990] | Inactive | Potency | | qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore) [AID892, Type: confirmatory] | Chain A, Solution Structure Of The Brct-C Domain From Human Brca1 [gi:159162802] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore) | | AID | 892 | | BioAssay type | confirmatory | | Target | Chain A, Solution Structure Of The Brct-C Domain From Human Brca1 [gi:159162802] | | PubMed | | | Data Table |  |
|
| 37 | [SID849990] | Inactive | Potency | | qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore) [AID875, Type: confirmatory] | Chain A, Solution Structure Of The Brct-C Domain From Human Brca1 [gi:159162802] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore) | | AID | 875 | | BioAssay type | confirmatory | | Target | Chain A, Solution Structure Of The Brct-C Domain From Human Brca1 [gi:159162802] | | PubMed | | | Data Table |  |
|
| 38 | [SID849990] | Inactive | | | uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay [AID602438, Type: screening] | Chain A, Crystal Structure Of The B1b2 Domains From Human Neuropilin- 1 [gi:160877737] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | BioAssay | uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay | | AID | 602438 | | BioAssay type | screening | | Target | Chain A, Crystal Structure Of The B1b2 Domains From Human Neuropilin- 1 [gi:160877737] | | PubMed | | | Data Table |  |
|
| 39 | [SID849990] | Inactive | Potency | | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 40 | [SID849990] | Inactive | | | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set [AID588497, Type: Literature] | botulinum neurotoxin type F, BoNT/F [Clostridium botulinum Bf] [gi:168184763] |   View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | BioAssay | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | | AID | 588497 | | BioAssay type | Literature | | Target | botulinum neurotoxin type F, BoNT/F [Clostridium botulinum Bf] [gi:168184763] | | PubMed | 16604538 | | Data Table |  |
|
| 41 | [SID849990] | Inactive | Potency | | qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS [AID602332, Type: confirmatory] | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) [Homo sapiens] [gi:168984549] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS | | AID | 602332 | | BioAssay type | confirmatory | | Target | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) [Homo sapiens] [gi:168984549] | | PubMed | | | Data Table |  |
|
| 42 | [SID849990] | Inactive | Potency | | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 43 | [SID849990] | Inactive | Potency | | qHTS Assay for Inhibitors of Influenza NS1 Protein Function [AID2326, Type: confirmatory] | nonstructural protein 1 [Influenza A virus (A/WSN/1933(H1N1))] [gi:194352380] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Influenza NS1 Protein Function | | AID | 2326 | | BioAssay type | confirmatory | | Target | nonstructural protein 1 [Influenza A virus (A/WSN/1933(H1N1))] [gi:194352380] | | PubMed | | | Data Table |  |
|
| 44 | [SID849990] | Inactive | IC50 | | Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition [AID588689, Type: confirmatory] | Chain A, Crystal Structure Of Dengue-2 Virus Methyltransferase Complexed With S-Adenosyl-L-Homocyste [gi:219689243] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition | | AID | 588689 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Dengue-2 Virus Methyltransferase Complexed With S-Adenosyl-L-Homocyste [gi:219689243] | | PubMed | | | Data Table |  |
|
| 45 | [SID849990] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen [AID2100, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen | | AID | 2100 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 46 | [SID849990] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen [AID2100, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen | | AID | 2100 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 47 | [SID849990] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen [AID2100, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen | | AID | 2100 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 48 | [SID849990] | Inactive | Potency | | qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease [AID1466, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease | | AID | 1466 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 49 | [SID849990] | Inactive | Potency | | qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease [AID1466, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease | | AID | 1466 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 50 | [SID849990] | Inactive | Potency | | qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease [AID1466, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 849990 | | CID | 54684098 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease | | AID | 1466 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|